- Home
- PALI vs SPRC Comparison
PALI vs SPRC Comparison
Compare PALI & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PALI
- SPRC
- Stock Information
- Founded
- PALI 1996
- SPRC 2004
- Country
- PALI United States
- SPRC Israel
- Employees
- PALI N/A
- SPRC N/A
- Industry
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- PALI Health Care
- SPRC Health Care
- Exchange
- PALI Nasdaq
- SPRC Nasdaq
- Market Cap
- PALI 3.2M
- SPRC 3.1M
- IPO Year
- PALI N/A
- SPRC N/A
- Fundamental
- Price
- PALI $0.76
- SPRC $0.35
- Analyst Decision
- PALI Strong Buy
- SPRC
- Analyst Count
- PALI 2
- SPRC 0
- Target Price
- PALI $23.00
- SPRC N/A
- AVG Volume (30 Days)
- PALI 92.4K
- SPRC 5.8M
- Earning Date
- PALI 05-20-2025
- SPRC 02-15-2025
- Dividend Yield
- PALI N/A
- SPRC N/A
- EPS Growth
- PALI N/A
- SPRC N/A
- EPS
- PALI N/A
- SPRC N/A
- Revenue
- PALI N/A
- SPRC $1,306,000.00
- Revenue This Year
- PALI N/A
- SPRC N/A
- Revenue Next Year
- PALI N/A
- SPRC N/A
- P/E Ratio
- PALI N/A
- SPRC N/A
- Revenue Growth
- PALI N/A
- SPRC N/A
- 52 Week Low
- PALI $0.60
- SPRC $0.20
- 52 Week High
- PALI $8.57
- SPRC $1.79
- Technical
- Relative Strength Index (RSI)
- PALI 50.38
- SPRC 57.38
- Support Level
- PALI $0.66
- SPRC $0.29
- Resistance Level
- PALI $0.83
- SPRC $0.50
- Average True Range (ATR)
- PALI 0.07
- SPRC 0.04
- MACD
- PALI 0.01
- SPRC 0.01
- Stochastic Oscillator
- PALI 61.71
- SPRC 39.52
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.